Abstract:BACKGROUND:Although a number of clinical and preclinical studies have demonstrated analgesic effects of cannabinoid treatments, there are also instances when cannabinoids have had no effect or even exacerbated pain. The observed pro-nociceptive effects appear to be due to cannabinoid-induced disinhibition of afferent synaptic input to nociceptive circuits. To better understand how cannabinoid-mediated plasticity can have both pro- and anti-nociceptive effects, we examined the possibility that cannabinoids differentially modulate nociceptive vs. non-nociceptive synapses onto a shared postsynaptic target. These experiments were carried out in the central nervous system (CNS) of the medicinal leech, in which it is possible to intracellularly record from presynaptic nociceptive (N-cell) or pressure-sensitive (P-cell) neurons and their shared postsynaptic targets.RESULTS:The endocannabinoid 2-arachidonoyl glycerol (2AG) elicited significant long-lasting depression in nociceptive (N-cell) synapses. However, non-nociceptive (P-cell) synapses were potentiated following 2AG treatment. 2AG-induced potentiation of non-nociceptive synapses was blocked by the TRPV antagonist SB366791, suggesting involvement of the same TRPV-like receptor that has already been shown to mediate endocannabinoid-dependent depression in nociceptive inputs. Treatment with the GABA receptor antagonist bicuculline also blocked 2AG-induced potentiation, consistent with the idea that increased synaptic signaling was the result of endocannabinoid-mediated disinhibition. Interestingly, while bicuculline by itself increased non-nociceptive synaptic transmission, nociceptive synapses were depressed by this GABA receptor antagonist indicating that nociceptive synapses were actually excited by GABAergic input. Consistent with these observations, GABA application depolarized the nociceptive afferent and hyperpolarized the non-nociceptive afferent.CONCLUSIONS:These findings show that endocannabinoids can differentially modulate nociceptive vs. non-nociceptive synapses and that GABAergic regulation of these synapses plays an important role in determining whether endocannabinoids have a potentiating or depressing effect.

[Progress in study on endocannabinoids and cannabinoid receptors in the treatment for neuropathic pain].

Correction: Divergent Modulation of Pain and Anxiety by GABAergic Neurons in the Ventrolateral Periaqueductal Gray and Dorsal Raphe.

The Endocannabinoid System in the Brain Undergoes Long-Lasting Changes Following Neuropathic Pain

The endocannabinoid system as a therapeutic target in neuropathic pain: a review

Targeting Long‐term Depression of Excitatory Synaptic Transmission for the Treatment of Neuropathic Pain

Cannabinoid Modulations of Pain- and Stress-Related Circuits

[Role of Cannabinoid Receptor 1-Mediated Synaptic Plasticity in Neuropathic Pain and Associated Depression].

Differential Modulation of Nociceptive Versus Non-Nociceptive Synapses by Endocannabinoids.

Analgesic Properties of Next-Generation Modulators of Endocannabinoid Signaling: Leveraging Modern Tools for the Development of Novel Therapeutics

Latest research progress and treatment strategy of neuropathic pain

Endocannabinoid system: Role in depression, reward and pain control (Review).

Bioactive compounds for neuropathic pain: An update on preclinical studies and future perspectives

Different neuronal populations mediate inflammatory pain analgesia by exogenous and endogenous opioids

Researchof analgesic effect and signaling pathways for opioid receptor agonists

Transcriptomic Profiling in Mice With CB1 receptor Deletion in Primary Sensory Neurons Suggests New Analgesic Targets for Neuropathic Pain

Role of Neuromodulation and Optogenetic Manipulation in Pain Treatment

Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia

Advances in Roles of Substance P and Substance P Receptor in Neuropathic Pain

Wnt signaling: A prospective therapeutic target for chronic pain

New Development of Analgesics Brought about by Studies on Pain

Epigenetic regulation of beta-endorphin synthesis in hypothalamic arcuate nucleus neurons modulates neuropathic pain in a rodent pain model